Association between preoperative 25-hydroxyvitamin D level and hospital-acquired infections following roux-en-Y gastric bypass surgery

JAMA Surgery

Volumn 149, Issue 2, 2014, Pages 112-118

  Quraishi, Sadeq A ^a   Bittner, Edward A ^a   Blum, Livnat ^a   Hutter, Mathew M ^a   Camargo Jr , Carlos A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKERS; CROSS INFECTION; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; INCIDENCE; MALE; MASSACHUSETTS; MIDDLE AGED; OBESITY, MORBID; ODDS RATIO; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84894550676     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.3176     Document Type: Article

References (48)

1. Ranji SR, Shetty K, Posley KA, et al. Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol 6: Prevention of Healthcare-Associated Infections). Rockville, MD: Agency for Healthcare Research and Quality; 2007.
2. Guggenbichler JP, Assadian O, BoeswaldM, Kramer A. Incidence and clinical implication of nosocomial infections associated with implantable biomaterials: catheters, ventilator-associated pneumonia, urinary tract infections. GMS Krankenhhyg Interdiszip. 2011;6(1):doc18.
3. Roberts RR, Scott RD II, Hota B, et al. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care. 2010;48(11):1026-1035.
4. Welsh CA, Flanagan ME, Hoke SC, Doebbeling BN, Herwaldt L; Agency for Healthcare Research and Quality Hospital-Acquired Infections Collaborative. Reducing health care-associated infections (HAIs): lessons learned from a national collaborative of regional HAI programs. Am J Infect Control. 2012;40(1):29-34.
5. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160-166.
6. Scott RD. The Direct Medical Costs of Healthcare-Associated Infections in US Hospitals and the Benefits of Prevention. Atlanta, GA: Centers for Disease Control and Prevention; 2009.
7. Youssef DA, Ranasinghe T, Grant WB, Peiris AN. Vitamin D's potential to reduce the risk of hospital-acquired infections. Dermatoendocrinol. 2012;4(2):167-175.
8. MartoneWJ, Nichols RL. Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis. 2001;33(suppl 2):S67-S68.
9. Anderson DJ. Surgical site infections. Infect Dis Clin North Am. 2011;25(1):135-153.
10. Salkind AR, Rao KC. Antiobiotic prophylaxis to prevent surgical site infections. Am FamPhysician. 2011;83(5):585-590.
11. Qadan M, Akça O, Mahid SS, Hornung CA, Polk HC Jr. Perioperative supplemental oxygen therapy and surgical site infection: ameta-analysis of randomized controlled trials. Arch Surg. 2009;144(4):359-366, discussion 366-367.
12. Ata A, Lee J, Bestle SL, Desemone J, Stain SC. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010;145(9):858-864.
13. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg. 2012;256(2):235-244.
14. Shokoohi A, Stanworth S,Mistry D, Lamb S, Staves J, MurphyMF. The risks of red cell transfusion for hip fracture surgery in the elderly. Vox Sang. 2012;103(3):223-230.
15. Beltramini AM, Salata RA, Ray AJ. Thermoregulation and risk of surgical site infection. Infect Control Hosp Epidemiol. 2011;32(6):603-610.
16. Qadan M, Gardner SA, Vitale DS, Lominadze D, Joshua IG, Polk HC Jr. Hypothermia and surgery: immunologic mechanisms for current practice. Ann Surg. 2009;250(1):134-140.
17. Chang CC, Lin HC, Lin HW, Lin HC. Anesthetic management and surgical site infections in total hip or knee replacement: a population-based study. Anesthesiology. 2010;113(2):279-284.
18. Cardinale F, Mastrototaro MF, Cappiello A, et al. Immunological modifications induced from products used during the perioperative period. Int J Immunopathol Pharmacol. 2011;24(3)(suppl):s13-s20.
19. von Dossow V, Sander M, MacGill M, Spies C. Perioperative cell-mediated immune response. Front Biosci. 2008;13:3676-3684.
20. Kawasaki T, Sata T. Perioperative innate immunity and its modulation. J UOEH. 2011;33(2):123-137.
21. Youssef DA,Miller CW, El-Abbassi AM, et al. Antimicrobial implications of vitamin D. Dermatoendocrinol. 2011;3(4):220-229.
22. Quraishi SA, Camargo CA Jr. Vitamin D in acute stress and critical illness. Curr Opin Clin NutrMetab Care. 2012;15(6):625-634.
23. Fish E, Beverstein G, Olson D, Reinhardt S, GarrenM, Gould J. Vitamin D status of morbidly obese bariatric surgery patients. J Surg Res. 2010;164(2):198-202.
24. Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 2006;10(7):1033-1037.
25. Christou NV, Jarand J, Sylvestre J-L, McLean APH. Analysis of the incidence and risk factors for wound infections in open bariatric surgery. Obes Surg. 2004;14(1):16-22.
26. Nguyen NT, PayaM, Stevens CM, Mavandadi S, Zainabadi K, Wilson SE. The relationship between hospital volume and outcome in bariatric surgery at academic medical centers. Ann Surg. 2004;240(4):586-593, discussion 593-594.
27. Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. Int J Obes (Lond). 2013;37(3):333-340.
28. Staehr AK, Meyhoff CS, Rasmussen LS; PROXI Trial Group. Inspiratory oxygen fraction and postoperative complications in obese patients: a subgroup analysis of the PROXI trial. Anesthesiology. 2011;114(6):1313-1319.
29. Nandipati K, Lin E, Husain F, et al. Factors predicting the increased risk for return to the operating room in bariatric patients: a NSQIP database study. Surg Endosc. 2013;27(4):1172-1177.
30. Hooton TM, Bradley SF, Cardenas DD, et al Infectious Diseases Society of America. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625-663.
31. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416.
32. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-332.
33. Steiner PM, Guo S, FraserMW. Propensity score analysis: statistical methods and applications. Psychometrika. 2010;75(4):775-777. doi:10.1007/s11336-010-9170-8.
34. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8, pt 2):757-763.
35. Rassen JA, Shelat AA,Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(suppl 2):69-80.
36. ClevelandWS. Robust locally weighted regression and smoothing scatterplots. J AmStat Assoc. 1979;74(368):829-836. doi:10.1080/01621459.1979. 10481038.
37. ClevelandWS, Devlin SJ. Locally weighted regression: an approach to regression analysis by local fitting. J AmStat Assoc. 1988;83(403): 596-610. doi:10.1080/01621459.1988.10478639.
38. HolickMF, Binkley NC, Bischoff-Ferrari HA, et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
39. HolickMF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
40. Quraishi S, Camargo C Jr. Vitamin D and major chronic illness. J Restor Med. 2012;1(1):9-23.
41. Jeng L, Yamshchikov AV, Judd SE, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med. 2009;7:28.
42. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770- 1773.
43. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008;4(2):80-90.
44. FabriM, Stenger S, Shin DM, et al. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med. 2011;3(104):104ra102.
45. Dürr UHN, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta. 2006;1758(9):1408-1425.
46. Tollin M, Bergman P, Svenberg T, Jörnvall H, Gudmundsson GH, Agerberth B. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides. 2003;24(4):523-530.
47. Bhan I, Camargo CA Jr,Wenger J, et al. Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults. J Allergy Clin Immunol. 2011;127(5):1302-1304.e1.
48. Dixon BM, Barker T, McKinnon T, et al. Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res Notes. 2012;5(1):575.